Home / Science / Dog's Cancer Vanquished by AI-Designed Vaccine
Dog's Cancer Vanquished by AI-Designed Vaccine
14 Mar
Summary
- An AI-designed mRNA vaccine shrank a dog's tumor by 75%.
- The custom vaccine was developed using the dog's DNA sequence.
- This breakthrough may pave the way for human cancer treatments.
A Sydney tech entrepreneur has pioneered a novel approach to treating canine cancer using an AI-designed mRNA vaccine. Rosie, an eight-year-old dog, was diagnosed with mast cell cancer, a common skin cancer in canines. Despite costly veterinary chemotherapy, the tumors on her leg continued to grow.
Paul Conyngham, Rosie's owner, leveraged AI technology, including ChatGPT, to sequence Rosie's tumor DNA. This data was then used to design a unique mRNA vaccine. Professor Páll Thordarson of the UNSW RNA Institute collaborated to produce the vaccine within two months.
The personalized vaccine has proven remarkably effective, shrinking Rosie's tumors by 75% in approximately one month. This significant improvement has restored her mobility, allowing her to engage in activities she previously couldn't. Mr. Conyngham expressed his deep commitment to Rosie, citing her as a constant support through personal challenges.
Experts suggest that this groundbreaking vaccine, developed in Australia, holds immense potential for future human cancer treatments. The success with Rosie demonstrates the feasibility of democratizing personalized medicine and could extend to treating other diseases, such as neurological conditions.
